Report Store mobile icon
Global Pharmaceutical Excipients Market Growth 2024-2030
Global Pharmaceutical Excipients Market Growth 2024-2030

2024

Global Pharmaceutical Excipients Market Growth 2024-2030

Pharmaceutical Excipients, valued at US$ 91.08 billion in 2023, are forecasted to reach US$ 135.24 billion by 2030, with a 5.8% CAGR due to rising demand in downstream sectors.

Buy Now Get Free sample

New Report Guarantee

If you purchase this report now and we update it in new 100 days, get it free!

According to Publisher’s latest study, the global Pharmaceutical Excipients market size was valued at US$ 91080 million in 2023. With the growing demand in the downstream market, the Pharmaceutical Excipients are forecast to a readjusted size of US$ 135240 million by 2030 with a CAGR of 5.8% during the review period. Market Overview

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

The research report highlights the growth potential of the global Pharmaceutical Excipients market. Pharmaceutical Excipients are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimisation remain crucial for the widespread adoption of Pharmaceutical Excipients. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalise on the immense opportunities presented by the Pharmaceutical Excipients market. Key Features: The report on the Pharmaceutical Excipients market reflects various aspects and provides valuable insights into the industry.

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant

Market Size and Growth: The research report provides an overview of the current size and growth of the Pharmaceutical Excipients market. It may include historical data, market segmentation by Type (e.g., Cellulose and Derivatives, Starch and Derivatives), and regional breakdowns. Market Drivers: The market for pharmaceutical excipients is being driven by the rising demand for pharmaceutical products and generic medications. The market for pharmaceutical excipients is anticipated to gain from the rising popularity of generic medications. Because they are less expensive than branded medications, generics are anticipated to increase sales volume when they enter the market. The patent cliff has increased the approval of generic drugs. Prominent US-based pharmaceutical companies, including Torrent Pharma, Aurobindo Pharma, Zydus Lifesciences, and Ajanta Pharma, are expected to benefit greatly from this breakthrough. Excipients can be an important cost-saving strategy for generic medication producers, who are always seeking methods to cut expenses. The pharmaceutical excipient industry is driven by the consequent increase in demand for excipients that are both high-quality and reasonably priced. This is regarded as a sign that the market for pharmaceutical excipients is expanding.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

Challenges-Novel excipients come with high development costs. New excipient approval procedures can be drawn out, costly, and complicated. Pharmaceutical businesses may find it more difficult to justify their investment in developing new medicines due to the high capital costs involved and the potential for further delays in the time to market for novel excipients. The FDA and other regulatory bodies must approve new excipients before they may be used in pharmaceutical products. To meet the demands of the pharmaceutical business, these excipients also need to be produced in big quantities. It is anticipated that this procedure, which can be expensive and time-consuming, will limit the market. Strict Rules and Regulations. The market for pharmaceutical excipients has a lot of challenges because of strict regulatory regulations. Regulations governing the production, testing, and application of excipients have been put in place by regulatory organizations such as the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA). The purpose of these rules is to guarantee the effectiveness and safety of pharmaceuticals. Strict legal constraints, nevertheless, can also make creating and releasing novel excipients onto the market more difficult. Because of this, excipient manufacturers may find it difficult to stay innovative and meet the changing needs of the pharmaceutical sector. The European Medicines Agency's (EMA) regulatory regulations and the strict New Drug Application (NDA) process of the U.S. FDA, for instance, can cause major delays in the release of novel excipients. Technological Developments: The research report can delve into the latest technological developments in the Pharmaceutical Excipients industry. This includes advancements in Pharmaceutical Excipients technology, Pharmaceutical Excipients new entrants, Pharmaceutical Excipients new investment, and other innovations that are shaping the future of Pharmaceutical Excipients. Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Pharmaceutical Excipients market. It includes factors influencing customers' purchasing decisions, and preferences for Pharmaceutical Excipients products. Government Policies and Incentives: The research report analyses the impact of government policies and incentives on the Pharmaceutical Excipients market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting the Pharmaceutical Excipients market. The report also evaluates the effectiveness of these policies in driving market growth. Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provides market forecasts and outlook for the Pharmaceutical Excipients industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments. Recommendations and Opportunities: The use of functional and multifunctional pharmaceutical excipients is growing. A kind of pharmaceutical excipient known as co-processed multifunctional excipients is produced by physically combining two or more excipients through granulation, blending, or mixing. Through this process, each excipient's physical characteristics are changed, creating a new excipient with improved functionality. These excipients have several advantages over single-function excipients currently on the market. They reduce variability in formulation properties by guaranteeing consistent batch-to-batch performance of pharmaceutical formulations, which opens lucrative opportunities for future market growth. They also improve formulation performance by having superior flowability, compressibility, binding, and disintegrating properties compared to individual excipients. Recent developments- October 2023 saw the launch of Clariant's portfolio of high-performing pharmaceutical ingredient solutions, a speciality chemicals firm with a focus on sustainability, to aid in the development of safe and effective medications. Additionally, to address issues with active pharmaceutical ingredient (API) distribution and bioavailability, Clariant Health Care increased the variety of functional excipients in its portfolio. September 20, 2023: Three new excipient grades have been added to Roquette's portfolio of solutions for moisture-sensitive active pharmaceutical and nutraceutical components. Roquette is a plant-based ingredient provider. Market Segmentation: The pharmaceutical Excipients market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. In terms of Production, Cellulose and Derivatives is the largest segment, with a share of over 51%. In terms of Application, the largest application is Solid Preparation Excipients, followed by Semi-Solid Preparation Excipients, Liquid Preparation Excipients, etc. 1. Segmentation by type • Cellulose and Derivatives • Starch and Derivatives • Inorganic Salts • Medicinal Sucrose • Other 2. Segmentation by application • Formulation Stability Excipients • Solid Preparation Excipients • Semi-Solid Preparation Excipients • Liquid Preparation Excipients • Other Regional Insights: North America is the largest market, with a share of about 33%, followed by Europe and Asia Pacific, which have a share of over 57 per cent. 1. Americas • United States • Canada • Mexico • Brazil 2. APAC • China • Japan • Korea • Southeast Asia • India • Australia 3. Europe • Germany • France • UK • Italy • Russia 4. Middle East & Africa • Egypt • South Africa • Israel • Turkey • GCC Countries Global Pharmaceutical Excipient's key players include Hnerkang?DowDuPont (FMC)?JRS Pharma?BASF?Lubrizol?Ashland?Croda International?Roquette?Shin-Etsu?Evonik, etc. Global top ten manufacturers hold a share of about 4%. The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. • DuPont (FMC) • JRS Pharma • BASF • Lubrizol • Ashland • Croda International • Roquette • Shin-Etsu • Evonik • Associated British Foods • Hnerkang • Anhui Sunhere Pharmaceutical Excipients • Chase Sun

Table of Contents

  • 1 Scope of the Report
  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats
  • 2 Executive Summary
  • 2.1 World Market Overview
  • 2.1.1 Global Pharmaceutical Excipients Annual Sales 2019-2030
  • 2.1.2 World Current & Future Analysis for Pharmaceutical Excipients by Geographic Region, 2019, 2023 & 2030
  • 2.1.3 World Current & Future Analysis for Pharmaceutical Excipients by Country/Region, 2019, 2023 & 2030
  • 2.2 Pharmaceutical Excipients Segment by Type
  • 2.2.1 Cellulose and Derivatives
  • 2.2.2 Starch and Derivatives
  • 2.2.3 Inorganic Salts
  • 2.2.4 Medicinal Sucrose
  • 2.2.5 Other
  • 2.3 Pharmaceutical Excipients Sales by Type
  • 2.3.1 Global Pharmaceutical Excipients Sales Market Share by Type (2019-2024)
  • 2.3.2 Global Pharmaceutical Excipients Revenue and Market Share by Type (2019-2024)
  • 2.3.3 Global Pharmaceutical Excipients Sale Price by Type (2019-2024)
  • 2.4 Pharmaceutical Excipients Segment by Application
  • 2.4.1 Formulation Stability Excipients
  • 2.4.2 Solid Preparation Excipients
  • 2.4.3 Semi-Solid Preparation Excipients
  • 2.4.4 Liquid Preparation Excipients
  • 2.4.5 Other
  • 2.5 Pharmaceutical Excipients Sales by Application
  • 2.5.1 Global Pharmaceutical Excipients Sale Market Share by Application (2019-2024)
  • 2.5.2 Global Pharmaceutical Excipients Revenue and Market Share by Application (2019-2024)
  • 2.5.3 Global Pharmaceutical Excipients Sale Price by Application (2019-2024)
  • 3 Global Pharmaceutical Excipients by Company
  • 3.1 Global Pharmaceutical Excipients Breakdown Data by Company
  • 3.1.1 Global Pharmaceutical Excipients Annual Sales by Company (2019-2024)
  • 3.1.2 Global Pharmaceutical Excipients Sales Market Share by Company (2019-2024)
  • 3.2 Global Pharmaceutical Excipients Annual Revenue by Company (2019-2024)
  • 3.2.1 Global Pharmaceutical Excipients Revenue by Company (2019-2024)
  • 3.2.2 Global Pharmaceutical Excipients Revenue Market Share by Company (2019-2024)
  • 3.3 Global Pharmaceutical Excipients Sale Price by Company
  • 3.4 Key Manufacturers Pharmaceutical Excipients Producing Area Distribution, Sales Area, Product Type
  • 3.4.1 Key Manufacturers Pharmaceutical Excipients Product Location Distribution
  • 3.4.2 Players Pharmaceutical Excipients Products Offered
  • 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion
  • 4 World Historic Review for Pharmaceutical Excipients by Geographic Region
  • 4.1 World Historic Pharmaceutical Excipients Market Size by Geographic Region (2019-2024)
  • 4.1.1 Global Pharmaceutical Excipients Annual Sales by Geographic Region (2019-2024)
  • 4.1.2 Global Pharmaceutical Excipients Annual Revenue by Geographic Region (2019-2024)
  • 4.2 World Historic Pharmaceutical Excipients Market Size by Country/Region (2019-2024)
  • 4.2.1 Global Pharmaceutical Excipients Annual Sales by Country/Region (2019-2024)
  • 4.2.2 Global Pharmaceutical Excipients Annual Revenue by Country/Region (2019-2024)
  • 4.3 Americas Pharmaceutical Excipients Sales Growth
  • 4.4 APAC Pharmaceutical Excipients Sales Growth
  • 4.5 Europe Pharmaceutical Excipients Sales Growth
  • 4.6 Middle East & Africa Pharmaceutical Excipients Sales Growth
  • 5 Americas
  • 5.1 Americas Pharmaceutical Excipients Sales by Country
  • 5.1.1 Americas Pharmaceutical Excipients Sales by Country (2019-2024)
  • 5.1.2 Americas Pharmaceutical Excipients Revenue by Country (2019-2024)
  • 5.2 Americas Pharmaceutical Excipients Sales by Type
  • 5.3 Americas Pharmaceutical Excipients Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil
  • 6 APAC
  • 6.1 APAC Pharmaceutical Excipients Sales by Region
  • 6.1.1 APAC Pharmaceutical Excipients Sales by Region (2019-2024)
  • 6.1.2 APAC Pharmaceutical Excipients Revenue by Region (2019-2024)
  • 6.2 APAC Pharmaceutical Excipients Sales by Type
  • 6.3 APAC Pharmaceutical Excipients Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan
  • 7 Europe
  • 7.1 Europe Pharmaceutical Excipients by Country
  • 7.1.1 Europe Pharmaceutical Excipients Sales by Country (2019-2024)
  • 7.1.2 Europe Pharmaceutical Excipients Revenue by Country (2019-2024)
  • 7.2 Europe Pharmaceutical Excipients Sales by Type
  • 7.3 Europe Pharmaceutical Excipients Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia
  • 8 Middle East & Africa
  • 8.1 Middle East & Africa Pharmaceutical Excipients by Country
  • 8.1.1 Middle East & Africa Pharmaceutical Excipients Sales by Country (2019-2024)
  • 8.1.2 Middle East & Africa Pharmaceutical Excipients Revenue by Country (2019-2024)
  • 8.2 Middle East & Africa Pharmaceutical Excipients Sales by Type
  • 8.3 Middle East & Africa Pharmaceutical Excipients Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends
  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis
  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Excipients
  • 10.3 Manufacturing Process Analysis of Pharmaceutical Excipients
  • 10.4 Industry Chain Structure of Pharmaceutical Excipients
  • 11 Marketing, Distributors and Customer
  • 11.1 Sales Channel
  • 11.1.1 Direct Channels
  • 11.1.2 Indirect Channels
  • 11.2 Pharmaceutical Excipients Distributors
  • 11.3 Pharmaceutical Excipients Customer
  • 12 World Forecast Review for Pharmaceutical Excipients by Geographic Region
  • 12.1 Global Pharmaceutical Excipients Market Size Forecast by Region
  • 12.1.1 Global Pharmaceutical Excipients Forecast by Region (2025-2030)
  • 12.1.2 Global Pharmaceutical Excipients Annual Revenue Forecast by Region (2025-2030)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Pharmaceutical Excipients Forecast by Type
  • 12.7 Global Pharmaceutical Excipients Forecast by Application
  • 13 Key Players Analysis
  • 13.1 DuPont (FMC)
  • 13.1.1 DuPont (FMC) Company Information
  • 13.1.2 DuPont (FMC) Pharmaceutical Excipients Product Portfolios and Specifications
  • 13.1.3 DuPont (FMC) Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.1.4 DuPont (FMC) Main Business Overview
  • 13.1.5 DuPont (FMC) Latest Developments
  • 13.2 JRS Pharma
  • 13.2.1 JRS Pharma Company Information
  • 13.2.2 JRS Pharma Pharmaceutical Excipients Product Portfolios and Specifications
  • 13.2.3 JRS Pharma Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.2.4 JRS Pharma Main Business Overview
  • 13.2.5 JRS Pharma Latest Developments
  • 13.3 BASF
  • 13.3.1 BASF Company Information
  • 13.3.2 BASF Pharmaceutical Excipients Product Portfolios and Specifications
  • 13.3.3 BASF Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.3.4 BASF Main Business Overview
  • 13.3.5 BASF Latest Developments
  • 13.4 Lubrizol
  • 13.4.1 Lubrizol Company Information
  • 13.4.2 Lubrizol Pharmaceutical Excipients Product Portfolios and Specifications
  • 13.4.3 Lubrizol Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.4.4 Lubrizol Main Business Overview
  • 13.4.5 Lubrizol Latest Developments
  • 13.5 Ashland
  • 13.5.1 Ashland Company Information
  • 13.5.2 Ashland Pharmaceutical Excipients Product Portfolios and Specifications
  • 13.5.3 Ashland Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.5.4 Ashland Main Business Overview
  • 13.5.5 Ashland Latest Developments
  • 13.6 Croda International
  • 13.6.1 Croda International Company Information
  • 13.6.2 Croda International Pharmaceutical Excipients Product Portfolios and Specifications
  • 13.6.3 Croda International Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.6.4 Croda International Main Business Overview
  • 13.6.5 Croda International Latest Developments
  • 13.7 Roquette
  • 13.7.1 Roquette Company Information
  • 13.7.2 Roquette Pharmaceutical Excipients Product Portfolios and Specifications
  • 13.7.3 Roquette Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.7.4 Roquette Main Business Overview
  • 13.7.5 Roquette Latest Developments
  • 13.8 Shin-Etsu
  • 13.8.1 Shin-Etsu Company Information
  • 13.8.2 Shin-Etsu Pharmaceutical Excipients Product Portfolios and Specifications
  • 13.8.3 Shin-Etsu Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.8.4 Shin-Etsu Main Business Overview
  • 13.8.5 Shin-Etsu Latest Developments
  • 13.9 Evonik
  • 13.9.1 Evonik Company Information
  • 13.9.2 Evonik Pharmaceutical Excipients Product Portfolios and Specifications
  • 13.9.3 Evonik Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.9.4 Evonik Main Business Overview
  • 13.9.5 Evonik Latest Developments
  • 13.10 Associated British Foods
  • 13.10.1 Associated British Foods Company Information
  • 13.10.2 Associated British Foods Pharmaceutical Excipients Product Portfolios and Specifications
  • 13.10.3 Associated British Foods Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.10.4 Associated British Foods Main Business Overview
  • 13.10.5 Associated British Foods Latest Developments
  • 13.11 Hnerkang
  • 13.11.1 Hnerkang Company Information
  • 13.11.2 Hnerkang Pharmaceutical Excipients Product Portfolios and Specifications
  • 13.11.3 Hnerkang Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.11.4 Hnerkang Main Business Overview
  • 13.11.5 Hnerkang Latest Developments
  • 13.12 Anhui Sunhere Pharmaceutical Excipients
  • 13.12.1 Anhui Sunhere Pharmaceutical Excipients Company Information
  • 13.12.2 Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Excipients Product Portfolios and Specifications
  • 13.12.3 Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.12.4 Anhui Sunhere Pharmaceutical Excipients Main Business Overview
  • 13.12.5 Anhui Sunhere Pharmaceutical Excipients Latest Developments
  • 13.13 Chase Sun
  • 13.13.1 Chase Sun Company Information
  • 13.13.2 Chase Sun Pharmaceutical Excipients Product Portfolios and Specifications
  • 13.13.3 Chase Sun Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.13.4 Chase Sun Main Business Overview
  • 13.13.5 Chase Sun Latest Developments
  • 14 Research Findings and Conclusion

List of Tables
Table 1. Pharmaceutical Excipients Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Pharmaceutical Excipients Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Cellulose and Derivatives
Table 4. Major Players of Starch and Derivatives
Table 5. Major Players of Inorganic Salts
Table 6. Major Players of Medicinal Sucrose
Table 7. Major Players of Other
Table 8. Global Pharmaceutical Excipients Sales by Type (2019-2024) & (K Ton)
Table 9. Global Pharmaceutical Excipients Sales Market Share by Type (2019-2024)
Table 10. Global Pharmaceutical Excipients Revenue by Type (2019-2024) & ($ million)
Table 11. Global Pharmaceutical Excipients Revenue Market Share by Type (2019-2024)
Table 12. Global Pharmaceutical Excipients Sale Price by Type (2019-2024) & (US$/Ton)
Table 13. Global Pharmaceutical Excipients Sales by Application (2019-2024) & (K Ton)
Table 14. Global Pharmaceutical Excipients Sales Market Share by Application (2019-2024)
Table 15. Global Pharmaceutical Excipients Revenue by Application (2019-2024)
Table 16. Global Pharmaceutical Excipients Revenue Market Share by Application (2019-2024)
Table 17. Global Pharmaceutical Excipients Sale Price by Application (2019-2024) & (US$/Ton)
Table 18. Global Pharmaceutical Excipients Sales by Company (2019-2024) & (K Ton)
Table 19. Global Pharmaceutical Excipients Sales Market Share by Company (2019-2024)
Table 20. Global Pharmaceutical Excipients Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Pharmaceutical Excipients Revenue Market Share by Company (2019-2024)
Table 22. Global Pharmaceutical Excipients Sale Price by Company (2019-2024) & (US$/Ton)
Table 23. Key Manufacturers Pharmaceutical Excipients Producing Area Distribution and Sales Area
Table 24. Players Pharmaceutical Excipients Products Offered
Table 25. Pharmaceutical Excipients Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Pharmaceutical Excipients Sales by Geographic Region (2019-2024) & (K Ton)
Table 29. Global Pharmaceutical Excipients Sales Market Share Geographic Region (2019-2024)
Table 30. Global Pharmaceutical Excipients Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Pharmaceutical Excipients Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Pharmaceutical Excipients Sales by Country/Region (2019-2024) & (K Ton)
Table 33. Global Pharmaceutical Excipients Sales Market Share by Country/Region (2019-2024)
Table 34. Global Pharmaceutical Excipients Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Pharmaceutical Excipients Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Pharmaceutical Excipients Sales by Country (2019-2024) & (K Ton)
Table 37. Americas Pharmaceutical Excipients Sales Market Share by Country (2019-2024)
Table 38. Americas Pharmaceutical Excipients Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Pharmaceutical Excipients Revenue Market Share by Country (2019-2024)
Table 40. Americas Pharmaceutical Excipients Sales by Type (2019-2024) & (K Ton)
Table 41. Americas Pharmaceutical Excipients Sales by Application (2019-2024) & (K Ton)
Table 42. APAC Pharmaceutical Excipients Sales by Region (2019-2024) & (K Ton)
Table 43. APAC Pharmaceutical Excipients Sales Market Share by Region (2019-2024)
Table 44. APAC Pharmaceutical Excipients Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Pharmaceutical Excipients Revenue Market Share by Region (2019-2024)
Table 46. APAC Pharmaceutical Excipients Sales by Type (2019-2024) & (K Ton)
Table 47. APAC Pharmaceutical Excipients Sales by Application (2019-2024) & (K Ton)
Table 48. Europe Pharmaceutical Excipients Sales by Country (2019-2024) & (K Ton)
Table 49. Europe Pharmaceutical Excipients Sales Market Share by Country (2019-2024)
Table 50. Europe Pharmaceutical Excipients Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Pharmaceutical Excipients Revenue Market Share by Country (2019-2024)
Table 52. Europe Pharmaceutical Excipients Sales by Type (2019-2024) & (K Ton)
Table 53. Europe Pharmaceutical Excipients Sales by Application (2019-2024) & (K Ton)
Table 54. Middle East & Africa Pharmaceutical Excipients Sales by Country (2019-2024) & (K Ton)
Table 55. Middle East & Africa Pharmaceutical Excipients Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Pharmaceutical Excipients Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Pharmaceutical Excipients Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Pharmaceutical Excipients Sales by Type (2019-2024) & (K Ton)
Table 59. Middle East & Africa Pharmaceutical Excipients Sales by Application (2019-2024) & (K Ton)
Table 60. Key Market Drivers & Growth Opportunities of Pharmaceutical Excipients
Table 61. Key Market Challenges & Risks of Pharmaceutical Excipients
Table 62. Key Industry Trends of Pharmaceutical Excipients
Table 63. Pharmaceutical Excipients Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Pharmaceutical Excipients Distributors List
Table 66. Pharmaceutical Excipients Customer List
Table 67. Global Pharmaceutical Excipients Sales Forecast by Region (2025-2030) & (K Ton)
Table 68. Global Pharmaceutical Excipients Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Pharmaceutical Excipients Sales Forecast by Country (2025-2030) & (K Ton)
Table 70. Americas Pharmaceutical Excipients Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Pharmaceutical Excipients Sales Forecast by Region (2025-2030) & (K Ton)
Table 72. APAC Pharmaceutical Excipients Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Pharmaceutical Excipients Sales Forecast by Country (2025-2030) & (K Ton)
Table 74. Europe Pharmaceutical Excipients Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Pharmaceutical Excipients Sales Forecast by Country (2025-2030) & (K Ton)
Table 76. Middle East & Africa Pharmaceutical Excipients Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Pharmaceutical Excipients Sales Forecast by Type (2025-2030) & (K Ton)
Table 78. Global Pharmaceutical Excipients Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Pharmaceutical Excipients Sales Forecast by Application (2025-2030) & (K Ton)
Table 80. Global Pharmaceutical Excipients Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. DuPont (FMC) Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 82. DuPont (FMC) Pharmaceutical Excipients Product Portfolios and Specifications
Table 83. DuPont (FMC) Pharmaceutical Excipients Sales (K Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 84. DuPont (FMC) Main Business
Table 85. DuPont (FMC) Latest Developments
Table 86. JRS Pharma Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 87. JRS Pharma Pharmaceutical Excipients Product Portfolios and Specifications
Table 88. JRS Pharma Pharmaceutical Excipients Sales (K Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 89. JRS Pharma Main Business
Table 90. JRS Pharma Latest Developments
Table 91. BASF Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 92. BASF Pharmaceutical Excipients Product Portfolios and Specifications
Table 93. BASF Pharmaceutical Excipients Sales (K Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 94. BASF Main Business
Table 95. BASF Latest Developments
Table 96. Lubrizol Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 97. Lubrizol Pharmaceutical Excipients Product Portfolios and Specifications
Table 98. Lubrizol Pharmaceutical Excipients Sales (K Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 99. Lubrizol Main Business
Table 100. Lubrizol Latest Developments
Table 101. Ashland Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 102. Ashland Pharmaceutical Excipients Product Portfolios and Specifications
Table 103. Ashland Pharmaceutical Excipients Sales (K Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 104. Ashland Main Business
Table 105. Ashland Latest Developments
Table 106. Croda International Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 107. Croda International Pharmaceutical Excipients Product Portfolios and Specifications
Table 108. Croda International Pharmaceutical Excipients Sales (K Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 109. Croda International Main Business
Table 110. Croda International Latest Developments
Table 111. Roquette Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 112. Roquette Pharmaceutical Excipients Product Portfolios and Specifications
Table 113. Roquette Pharmaceutical Excipients Sales (K Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 114. Roquette Main Business
Table 115. Roquette Latest Developments
Table 116. Shin-Etsu Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 117. Shin-Etsu Pharmaceutical Excipients Product Portfolios and Specifications
Table 118. Shin-Etsu Pharmaceutical Excipients Sales (K Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 119. Shin-Etsu Main Business
Table 120. Shin-Etsu Latest Developments
Table 121. Evonik Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 122. Evonik Pharmaceutical Excipients Product Portfolios and Specifications
Table 123. Evonik Pharmaceutical Excipients Sales (K Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 124. Evonik Main Business
Table 125. Evonik Latest Developments
Table 126. Associated British Foods Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 127. Associated British Foods Pharmaceutical Excipients Product Portfolios and Specifications
Table 128. Associated British Foods Pharmaceutical Excipients Sales (K Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 129. Associated British Foods Main Business
Table 130. Associated British Foods Latest Developments
Table 131. Hnerkang Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 132. Hnerkang Pharmaceutical Excipients Product Portfolios and Specifications
Table 133. Hnerkang Pharmaceutical Excipients Sales (K Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 134. Hnerkang Main Business
Table 135. Hnerkang Latest Developments
Table 136. Anhui Sunhere Pharmaceutical Excipients Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 137. Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Excipients Product Portfolios and Specifications
Table 138. Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Excipients Sales (K Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 139. Anhui Sunhere Pharmaceutical Excipients Main Business
Table 140. Anhui Sunhere Pharmaceutical Excipients Latest Developments
Table 141. Chase Sun Basic Information, Pharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 142. Chase Sun Pharmaceutical Excipients Product Portfolios and Specifications
Table 143. Chase Sun Pharmaceutical Excipients Sales (K Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 144. Chase Sun Main Business
Table 145. Chase Sun Latest Developments

Related Tags

Related Reports

payment cards

Allows one individual to access the purchased report Read More

Allows all employees of an organization to access the purchased report. Internal sharing only Read More

Allows all employees of an organization to access the purchased report. It also permits the use of up to 4 paragraphs or 1 page of the report externally in whitepapers, press releases, and marketing collateral Read More

Buy Now

Safe and Secure SSL Encrypted

Quick Contacts

Want to customize this report?

We offer 10% Free Customization at the time of purchase

Get Free Customization

I'm Available

Rishika Gupta

Rishika Gupta

Team Lead- Business Development

Trusted Partners

NONWOVENS_INDUSTRY
FB
issuewire
Financial_Express
logo_yourstory
FB

Budget constraints? Get in touch with us for special pricing

Request Discount

Order Detail

  • Order Placed (27 July, 2024)
  • Notify To Team (27 July, 2024)
  • Report updation (28 July, 2024)
  • Report Quality Check (28 July, 2024)
  • Report Dispatch (29 July, 2024)

  • paypal
  • icici
  • stripe
  • wire-transfer

  • Email
  • Hard Copy

Research Methodology

An Adaptive Approach to Modern-day Research Needs

Get Methodology

Recently Viewed Products

Logo

Global Pharmaceutical Excipients Market Growth 2024-2030

Contact usWe are friendly and approachable, give us a call.

We uses Cookies

We use cookies to ensure you get the best experience on our website.